explore -WSS

explore

author：Wikipedia 2025-10-01 18:34:19 - browse：17225

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： What health policies could hitch a ride on a spending bill?

WSS

Experimental asthma app from Apple and Anthem shows promise

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Today's health inequities arise from racist U.S. history, say experts

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Cancer diagnosis changes perspective doctor, former hospital CEO

hotspot

explore

Gilead needs Arcellx more than ever

explore

Peter Hotez and the public health issue of online harassment

Carbon Health diabetes program, a test of data

Alkermes shareholders re

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Medicare proposal to cover medical devices draws a mixed reaction

The wait for US passports is creating travel purgatory and snarling summer plans

Psychedelics group wrestles with new pharma identity

Medicare’s new pay boost for primary care is angering specialists

Supreme Court strikes down use of affirmative action

The wait for US passports is creating travel purgatory and snarling summer plans

hotspot

Canadians with cystic fibrosis outlive Americans by a decade

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

How Robert F. Kennedy Jr. distorted vaccine science

Undocumented workers face uncertainty as immigration law takes effect in Florida

Type 2 diabetes prevention programs work at large scale: study

Skip the lead apron during X

knowledge

hotspot

explore

Wikipedia